Juglone Attenuates CCl₄‐Induced Hepatic Injury in Mice With Associated Modulation of Oxidative Stress and Inflammasome‐Related mRNA Expression
Open Access
- 1 January 2026
- journal article
- Published by Wiley in BioMed Research International
- Vol. 2026 (1) , 8905392
Abstract
Carbon tetrachloride–induced liver injury is a well‐established model of toxic hepatitis, characterized by marked oxidative and inflammatory damage. It remains a relevant experimental system because broadly effective therapeutic options are still limited. Juglone, a natural naphthoquinone derived from Reynoutria japonica , has demonstrated antioxidant and anti‐inflammatory potential. However, mouse evidence combining standard liver injury measures with stress‐ and cell‐death gene profiling remains limited. Building on juglone studies in injury and fibrosis, we tested juglone in a CCl 4 model. Male C57BL/6 mice were assigned to normal, vehicle, CCl₄, silymarin (200 mg/kg), and juglone (8 mg/kg) groups, and CCl₄ (in corn oil) was administered intraperitoneally. Endpoints included body weight, serum liver enzymes and lipid profile, H&E histology, and RT‐qPCR panels for inflammatory, pyroptosis‐associated, ER stress and autophagy‐linked, apoptotic, oxidative‐stress, and profibrotic transcripts. CCl₄ exposure was associated with weight loss, enzyme elevation, dyslipidemia, and architectural disruption, whereas juglone treatment was associated with improved biochemical indices and histology alongside coordinated downregulation of inflammatory/pyroptosis‐related transcripts (including Il-1β , Il-6 , Nlrp3 , and Gsdmd ) and moderation of ER stress/autophagy and apoptosis‐linked transcripts, with downregulation of profibrotic transcripts ( Acta2 , Mmp2 , and Tgfβ1 ). In this mouse CCl₄ model, juglone treatment was associated with reduced serum and tissue injury signatures together with changes in stress and inflammation‐linked transcriptional programs. Because the molecular findings are primarily based on RT‐qPCR, these results are best interpreted as gene‐level associations compatible with modulation of oxidative stress, inflammasome‐ and pyroptosis‐related mRNA expression, ER stress responses, apoptosis‐linked transcripts, and remodeling‐associated transcripts, rather than as confirmed pathway inhibition or established antifibrotic activity. These data support juglone as a hepatoprotective candidate and identify protein‐level and functional validation as important next steps.Keywords
Funding Information
- National Research Foundation of Korea (RS-2025-25416339)
- Quaid-i-Azam University (URF 2020-2021)
This publication has 32 references indexed in Scilit:
- Salidroside protects mice against CCl4-induced acute liver injury via down-regulating CYP2E1 expression and inhibiting NLRP3 inflammasome activationInternational Immunopharmacology, 2020
- Mitochondrial DNA in liver inflammation and oxidative stressLife Sciences, 2019
- Medicinal plants and their traditional uses in the highland region of Bordj Bou Arreridj (Northeast Algeria)Journal of Herbal Medicine, 2019
- A new anti-Helicobacter pylori juglone from Reynoutria japonicaArchives of Pharmacal Research, 2019
- Animal models of drug-induced liver injuryBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2019
- Nrf2-Keap1 signaling in oxidative and reductive stressBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2018
- Drug Metabolism in the LiverClinics in Liver Disease, 2017
- Normal liver anatomyClinical Liver Disease, 2013
- Protective effect of Lygodium flexuosum (L.) Sw. extract against carbon tetrachloride-induced acute liver injury in ratsJournal of Ethnopharmacology, 2006
- Microanatomy of the human liver—exploring the hidden interfacesHepatology, 1999